Search

everythinglearnresearchcommunity

for

Search:↓

Graphene oxide helps deliver a skin healing agent over time, improving skin and hair follicle regeneration.

Dupilumab effectively controls symptoms in infants with Netherton syndrome.

CD2 might be a new treatment target for patchy alopecia areata.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Researchers found four genes that could help diagnose severe alopecia areata early.

JAK inhibitors for alopecia areata are linked to minor side effects like headache and acne, but not to an increased risk of serious adverse events.

Caffeine shows promise for treating some types of hair loss, but more research is needed.

Topical vitamin D is effective in treating vitiligo with few side effects.

Higher IL-15 levels are linked to more severe hair loss in alopecia areata.

Belimumab effectively controls SLE disease activity and reduces steroid use.

2011 dermatological research found new skin aging markers, hair loss causes, skin defense mechanisms, and potential for new treatments.

Topical tofacitinib is a safe and effective treatment for autoimmune skin disorders.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

People with certain skin diseases have higher levels of the hormone prolactin in their blood.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.

Oleoylethanolamide (OEA) safely boosts fat production in skin cells and may help treat dry skin and reduce inflammation.

New therapies for rare skin diseases show promise but need more research.

Upadacitinib improved multiple immune-related conditions in one patient.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

Small extracellular vesicles from stem and immune cells show promise for treating various diseases but face challenges in clinical use.

Ustekinumab and vedolizumab can help some ulcerative colitis patients with hair regrowth, but results vary.

People with alopecia areata have a higher risk of heart disease.

Dupilumab may cause hair loss, so patients should be monitored.

Mothers with alopecia areata have a higher risk of adverse birth outcomes.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Topical corticosteroids are the preferred first treatment for children with Alopecia Areata.